Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2020 2
2021 1
2022 1
2023 2
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
How to Report PSMA PET.
Swiha M, Ayati N, Oprea-Lager DE, Ceci F, Emmett L. Swiha M, et al. Semin Nucl Med. 2024 Jan;54(1):14-29. doi: 10.1053/j.semnuclmed.2023.07.007. Epub 2023 Aug 8. Semin Nucl Med. 2024. PMID: 37558507 Review.
Treatment Response Imaging in Prostate Cancer.
Swiha M, Gafita A, Nguyen A, Emmett L. Swiha M, et al. PET Clin. 2024 Jul;19(3):417-430. doi: 10.1016/j.cpet.2024.03.009. Epub 2024 Apr 25. PET Clin. 2024. PMID: 38670877 Review.
Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis.
Kafil TS, Shaikh OM, Fanous Y, Benjamen J, Hashmi MM, Jawad A, Dahrouj T, Abazid RM, Swiha M, Romsa J, Beanlands RSB, Ruddy TD, Mielniczuk L, Birnie DH, Tzemos N. Kafil TS, et al. Among authors: swiha m. JACC Cardiovasc Imaging. 2024 Sep;17(9):1079-1097. doi: 10.1016/j.jcmg.2024.05.013. Epub 2024 Aug 7. JACC Cardiovasc Imaging. 2024. PMID: 39115497
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS).
Swiha MM, Sutherland DEK, Sistani G, Khatami A, Abazid RM, Mujoomdar A, Wiseman DP, Romsa JG, Reid RH, Laidley DT. Swiha MM, et al. J Cancer Res Clin Oncol. 2022 Jan;148(1):225-236. doi: 10.1007/s00432-021-03672-w. Epub 2021 Jun 10. J Cancer Res Clin Oncol. 2022. PMID: 34110489 Free PMC article. Clinical Trial.
Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT.
Li S, Nguyen A, Counter W, John NC, De Leon J, Hruby G, Joshua AM, Stricker P, Crumbaker M, Ayati N, Chan L, Sabahi Z, Swiha M, Kneebone A, Wong K, Liu V, Sharma S, Agrawal S, Emmett LM. Li S, et al. Among authors: swiha m. J Nucl Med. 2024 Sep 3;65(9):1371-1375. doi: 10.2967/jnumed.124.267881. J Nucl Med. 2024. PMID: 39089814
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.
Alghamdi MA, Amaro CP, Lee-Ying R, Sim HW, Samwi H, Chan KK, Knox JJ, Ko YJ, Swiha M, Batuyong E, Romagnino A, Cheung WY, Tam VC; Hepatocellular Carcinoma - Cancer Health Outcomes Research Database (HCC - CHORD) Consortium. Alghamdi MA, et al. Among authors: swiha m. Cancer Med. 2020 Jul;9(14):4918-4928. doi: 10.1002/cam4.3228. Epub 2020 Jun 11. Cancer Med. 2020. PMID: 32529797 Free PMC article.
11 results